Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates.

Ko SY, Akahata W, Yang ES, Kong WP, Burke CW, Honnold SP, Nichols DK, Huang YS, Schieber GL, Carlton K, DaSilva L, Traina-Dorge V, Vanlandingham DL, Tsybovsky Y, Stephens T, Baxa U, Higgs S, Roy CJ, Glass PJ, Mascola JR, Nabel GJ, Rao SS.

Sci Transl Med. 2019 May 15;11(492). pii: eaav3113. doi: 10.1126/scitranslmed.aav3113.

PMID:
31092692
2.

Human-Like Neutralizing Antibodies Protect Mice from Aerosol Exposure with Western Equine Encephalitis Virus.

Burke CW, Froude JW, Miethe S, H├╝lseweh B, Hust M, Glass PJ.

Viruses. 2018 Mar 24;10(4). pii: E147. doi: 10.3390/v10040147.

4.

Mode of parainfluenza virus transmission determines the dynamics of primary infection and protection from reinfection.

Burke CW, Bridges O, Brown S, Rahija R, Russell CJ.

PLoS Pathog. 2013;9(11):e1003786. doi: 10.1371/journal.ppat.1003786. Epub 2013 Nov 21.

5.

Ultrasound-activated agents comprised of 5FU-bearing nanoparticles bonded to microbubbles inhibit solid tumor growth and improve survival.

Burke CW, Alexander E 4th, Timbie K, Kilbanov AL, Price RJ.

Mol Ther. 2014 Feb;22(2):321-328. doi: 10.1038/mt.2013.259. Epub 2013 Oct 31.

6.

Vitamin K deficiency bleeding: overview and considerations.

Burke CW.

J Pediatr Health Care. 2013 May-Jun;27(3):215-21. doi: 10.1016/j.pedhc.2012.09.010. Epub 2012 Nov 9. Review. No abstract available.

PMID:
23146661
7.

Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of non-viral gene nanocarriers with microbubbles.

Burke CW, Suk JS, Kim AJ, Hsiang YH, Klibanov AL, Hanes J, Price RJ.

J Control Release. 2012 Sep 10;162(2):414-21. doi: 10.1016/j.jconrel.2012.07.005. Epub 2012 Jul 16.

8.
9.

Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy.

Burke CW, Mason JN, Surman SL, Jones BG, Dalloneau E, Hurwitz JL, Russell CJ.

PLoS Pathog. 2011 Jul;7(7):e1002134. doi: 10.1371/journal.ppat.1002134. Epub 2011 Jul 7.

10.

Covalently linking poly(lactic-co-glycolic acid) nanoparticles to microbubbles before intravenous injection improves their ultrasound-targeted delivery to skeletal muscle.

Burke CW, Hsiang YH, Alexander E 4th, Kilbanov AL, Price RJ.

Small. 2011 May 9;7(9):1227-35. doi: 10.1002/smll.201001934. Epub 2011 Apr 1.

11.

Inhibition of glioma growth by microbubble activation in a subcutaneous model using low duty cycle ultrasound without significant heating.

Burke CW, Klibanov AL, Sheehan JP, Price RJ.

J Neurosurg. 2011 Jun;114(6):1654-61. doi: 10.3171/2010.11.JNS101201. Epub 2011 Jan 7.

12.
13.

Characteristics of alpha/beta interferon induction after infection of murine fibroblasts with wild-type and mutant alphaviruses.

Burke CW, Gardner CL, Steffan JJ, Ryman KD, Klimstra WB.

Virology. 2009 Dec 5;395(1):121-32. doi: 10.1016/j.virol.2009.08.039. Epub 2009 Sep 25.

14.

Capillary arterialization requires the bone-marrow-derived cell (BMC)-specific expression of chemokine (C-C motif) receptor-2, but BMCs do not transdifferentiate into microvascular smooth muscle.

Nickerson MM, Burke CW, Meisner JK, Shuptrine CW, Song J, Price RJ.

Angiogenesis. 2009;12(4):355-63. doi: 10.1007/s10456-009-9157-1. Epub 2009 Sep 24.

15.

Bone marrow-derived cell-specific chemokine (C-C motif) receptor-2 expression is required for arteriolar remodeling.

Nickerson MM, Song J, Meisner JK, Bajikar S, Burke CW, Shuptrine CW, Owens GK, Skalak TC, Price RJ.

Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1794-801. doi: 10.1161/ATVBAHA.109.194019. Epub 2009 Sep 4.

16.

Similarities and differences in antagonism of neuron alpha/beta interferon responses by Venezuelan equine encephalitis and Sindbis alphaviruses.

Yin J, Gardner CL, Burke CW, Ryman KD, Klimstra WB.

J Virol. 2009 Oct;83(19):10036-47. doi: 10.1128/JVI.01209-09. Epub 2009 Jul 29.

17.

Type I interferon induction is correlated with attenuation of a South American eastern equine encephalitis virus strain in mice.

Gardner CL, Yin J, Burke CW, Klimstra WB, Ryman KD.

Virology. 2009 Aug 1;390(2):338-47. doi: 10.1016/j.virol.2009.05.030. Epub 2009 Jun 18.

18.

Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis.

Gardner CL, Burke CW, Tesfay MZ, Glass PJ, Klimstra WB, Ryman KD.

J Virol. 2008 Nov;82(21):10634-46. doi: 10.1128/JVI.01323-08. Epub 2008 Sep 3.

19.

Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis.

Chappell JC, Song J, Burke CW, Klibanov AL, Price RJ.

Small. 2008 Oct;4(10):1769-77. doi: 10.1002/smll.200800806.

20.

Identification and characterization of interferon-induced proteins that inhibit alphavirus replication.

Zhang Y, Burke CW, Ryman KD, Klimstra WB.

J Virol. 2007 Oct;81(20):11246-55. Epub 2007 Aug 8.

21.

Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses.

Ryman KD, Gardner CL, Burke CW, Meier KC, Thompson JM, Klimstra WB.

J Virol. 2007 Apr;81(7):3563-73. Epub 2007 Jan 10.

22.

An account of the quality of life of patients after treatment for non-functioning pituitary tumours.

Page RC, Hammersley MS, Burke CW, Wass JA.

Clin Endocrinol (Oxf). 1997 Apr;46(4):401-6.

PMID:
9196600
23.

P53 protein accumulates in Cushings adenomas and invasive non-functional adenomas.

Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW, Clayton RN.

J Clin Endocrinol Metab. 1995 Feb;80(2):4 p following 692.

PMID:
7852482
24.
25.

p53 Protein accumulates in Cushings adenomas and invasive non-functional adenomas.

Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW, Clayton RN.

J Clin Endocrinol Metab. 1994 Nov;79(5):1513-6. Corrected and republished in: J Clin Endocrinol Metab. 1995 Feb;80(2):4 p following 692.

PMID:
7962351
26.

An audit of selected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation.

Bradley KM, Adams CB, Potter CP, Wheeler DW, Anslow PJ, Burke CW.

Clin Endocrinol (Oxf). 1994 Nov;41(5):655-9.

PMID:
7828355
27.

Current modes of treatment of pituitary tumours.

Adams CB, Burke CW.

Br J Neurosurg. 1993;7(2):123-7. Review. No abstract available.

PMID:
8494613
28.

Dopamine agonists and pituitary tumor shrinkage.

Bevan JS, Webster J, Burke CW, Scanlon MF.

Endocr Rev. 1992 May;13(2):220-40.

PMID:
1352243
29.

The pituitary megatest: outdated?

Burke CW.

Clin Endocrinol (Oxf). 1992 Feb;36(2):133-4. No abstract available.

PMID:
1314721
30.

Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome?

Burke CW, Adams CB, Esiri MM, Morris C, Bevan JS.

Clin Endocrinol (Oxf). 1990 Oct;33(4):525-37.

PMID:
2171817
31.

Vasopressin antagonist in early postoperative diabetes insipidus.

Seckl JR, Dunger DB, Bevan JS, Nakasu Y, Chowdrey C, Burke CW, Lightman SL.

Lancet. 1990 Jun 9;335(8702):1353-6.

PMID:
1971658
32.

The anterior pituitary, snakebite and Sheehan's syndrome.

Burke CW.

Q J Med. 1990 Apr;75(276):331-3. No abstract available.

PMID:
2143590
33.

Studies of two thyrotrophin-secreting pituitary adenomas: evidence for dopamine receptor deficiency.

Bevan JS, Burke CW, Esiri MM, Adams CB, Ballabio M, Nissim M, Faglia G.

Clin Endocrinol (Oxf). 1989 Jul;31(1):59-70.

PMID:
2598481
34.
35.

Intrasellar gangliocytoma containing gastrin and growth hormone-releasing hormone associated with a growth hormone-secreting pituitary adenoma.

Bevan JS, Asa SL, Rossi ML, Esiri MM, Adams CB, Burke CW.

Clin Endocrinol (Oxf). 1989 Mar;30(3):213-24.

PMID:
2512034
36.

The human leucocyte sodium pump in Cushing's syndrome.

Ng LL, Evans DJ, Burke CW.

Clin Endocrinol (Oxf). 1988 Feb;28(2):233-41.

PMID:
2844449
37.

Body fat topography in women with androgen excess.

Evans DJ, Barth JH, Burke CW.

Int J Obes. 1988;12(2):157-62.

PMID:
3384560
38.

Acute and chronic pituitary failure resembling Sheehan's syndrome following bites by Russell's viper in Burma.

Tun-Pe, Phillips RE, Warrell DA, Moore RA, Tin-Nu-Swe, Myint-Lwin, Burke CW.

Lancet. 1987 Oct 3;2(8562):763-7.

PMID:
2888987
39.

Hyperthyroidism in the elderly.

Burke CW.

J R Soc Med. 1987 Oct;80(10):661-2. No abstract available.

40.

The human leucocyte sodium pump in adrenocortical insufficiency.

Ng LL, Evans DJ, Burke CW.

Clin Endocrinol (Oxf). 1987 Aug;27(2):235-43.

PMID:
3665131
41.

Cushing's syndrome in pregnancy: the timing of definitive treatment.

Bevan JS, Gough MH, Gillmer MD, Burke CW.

Clin Endocrinol (Oxf). 1987 Aug;27(2):225-33.

PMID:
3665130
42.

Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy.

Bevan JS, Adams CB, Burke CW, Morton KE, Molyneux AJ, Moore RA, Esiri MM.

Clin Endocrinol (Oxf). 1987 May;26(5):541-56.

PMID:
3665118
43.

Pituitary apoplexy following isosorbide administration.

Bevan JS, Oza AM, Burke CW, Adams CB.

J Neurol Neurosurg Psychiatry. 1987 May;50(5):636-7. No abstract available.

44.

Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargement.

Bevan JS, Burke CW, Esiri MM, Adams CB.

Am J Med. 1987 Jan;82(1):29-32.

PMID:
3799691
45.

Sensitive and specific bromocriptine radioimmunoassay with iodine label: measurement of bromocriptine in human plasma.

Bevan JS, Baldwin D, Burke CW.

Ann Clin Biochem. 1986 Nov;23 ( Pt 6):686-93.

PMID:
3800295
47.
48.
49.

ACTH response to CRF in ACTH deficient patients.

Burke CW.

Clin Endocrinol (Oxf). 1985 Dec;23(6):722-4. No abstract available.

PMID:
3006949
50.

Adrenocortical insufficiency.

Burke CW.

Clin Endocrinol Metab. 1985 Nov;14(4):947-76. Review.

PMID:
3002680

Supplemental Content

Loading ...
Support Center